![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Saturday, June 26, 2021 10:00:33 PM
The NIH wants to see how well Aviptadil works in a controlled setting. It is basically a continuation of our trial with real time data streaming in.
This proves that they believe it is safe and MAY be effective. By putting Aviptadil in this trial and allowing the EAP to continue is all I need to know to feel confident that an EUA will be issued. Hold or load.
~ Money Making Money ~
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM